MicroRNA Variants Increase the Risk of HPV-Associated Squamous Cell Carcinoma of the Oropharynx in Never Smokers

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Song, Xicheng ^a,b   Sturgis, Erich M ^a   Liu, Jun ^a,c   Jin, Lei ^a,d   Wang, Zhongqiu ^a,e   Zhang, Caiyun ^f   Wei, Qingyi ^a   Li, Guojun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c SICHUAN UNIVERSITY   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

^e TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^f SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 146; MICRORNA 149; MICRORNA 196; MICRORNA 499; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION RISK; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OROPHARYNX CARCINOMA; PROTEIN MODIFICATION; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROLOGIC TESTS; SMOKING;

EID: 84874061898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056622     Document Type: Article

References (42)

1. Gillison ML, (2007) Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck 29: 779-792.
2. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP, (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114: 806-816.
3. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
4. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK, (1993) Head and neck cancer. N Engl J Med 328: 184-194.
5. Sturgis EM, Cinciripini PM, (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110: 1429-1435.
6. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML, (2008) Incidence trends for human papillomavirus-related and-unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26: 612-619.
7. Ernster JA, Sciotto CG, O'Brien MM, Finch JL, Robinson LJ, et al. (2007) Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 117: 2115-2128.
8. Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, et al. (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95: 1772-1783.
9. Fakhry C, Gillison ML, (2006) Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 24: 2606-2611.
10. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720.
11. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
12. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet 37: 766-770.
13. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34 (Database issue) (): D140-144.
14. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
15. Kloosterman WP, Plasterk RH, (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
16. Stefani G, Slack FJ, (2008) Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219-230.
17. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
18. Osada H, Takahashi T, (2007) MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 28: 2-12.
19. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
20. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
21. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J, (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 2094-2105.
22. Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, et al. (2007) MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 358: 12-17.
23. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901-1908.
24. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, et al. (2008) MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123: 2791-2797.
25. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
26. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2008) MicroRNAs and the immune response. Trends Immunol 29: 343-351.
27. Pedersen I, David M, (2008) MicroRNAs in the immune response. Cytokine 43: 391-394.
28. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105: 7269-7274.
29. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, et al. (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 14: 2588-2592.
30. Hu Z, Chen J, Tian T, Zhou X, Gu H, et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608.
31. Hu Z, Liang J, Wang Z, Tian T, Zhou X, et al. (2009) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30: 79-84.
32. Christensen BC, Avissar-Whiting M, Ouellet LG, Butler RA, Nelson HH, et al. (2010) Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 16: 3713-3720.
33. Liu Z, Li G, Wei S, Niu J, El-Naggar AK, et al. (2010) Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116: 4753-4760.
34. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, et al. (1994) A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer I 86: 494-499.
35. Dahlstrom KR, Adler-Storthz K, Etzel CJ, Liu Z, Dillon L, et al. (2003) Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res 9: 2620-2626.
36. Chen X, Sturgis EM, Lei D, Dahlstrom K, Wei Q, et al. (2010) Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. Cancer Res 70: 7199-7208.
37. Sonkoly E, Ståhle M, Pivarcsi A, (2008) MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18: 131-140.
38. Sonkoly E, Wei T, Janson PC, Sääf A, Lundeberg L, et al. (2007) MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2: e610.
39. Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ, (2007) High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 6: 5.
40. Liu X, Chen Z, Yu J, Xia J, Zhou X, (2009) MicroRNA profiling and head and neck cancer. Comp Funct Genomics pp. 837514.
41. Guo Y, Fu W, Chen H, Shang C, Zhong M, (2012) MiR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein. Oncol Rep 27: 1097-2103.
42. Henson BJ, Bhattacharjee S, O'Dee DM, Feingold E, Gollin SM, (2009) Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 48: 569-582.